首页> 外文会议>World biomaterials congress >Preclinical evaluation of collagen type Ⅰ scaffolds that include gelatin-collagen microparticles and are loaded with an aqueous aloe vera extract in a rodent model of full-thickness skin wound
【24h】

Preclinical evaluation of collagen type Ⅰ scaffolds that include gelatin-collagen microparticles and are loaded with an aqueous aloe vera extract in a rodent model of full-thickness skin wound

机译:Ⅰ型胶原蛋白Ⅰ型支架的临床前评价,包括明胶 - 胶原微粒,并在全厚度皮肤伤口啮齿动物模型中加载芦荟水溶液

获取原文

摘要

Scaffolds that support tissue growth can also be designed to control the release of plant extracts commonly used as wound healing agents. We have developed collagen type Ⅰ scaffolds containing microparticles of gelatin-collagen (CS-GC) that in vitro sustain the release of non-cytotoxic concentrations of an extract of Aloe vera during a span of time that matches the in vivo remodeling stages of skin healing. Worldwide, mucilage gel and extracts of this plant are used topically on skin as moisturizers, antiseptica, anti-inflammatories, etc. The use of A vera preparations to promote skin wound healing has been approved by The Colombian Drug Regulatory Agency (INVIMA). Here, we report on a pre-clinical evaluation of the performance of a CS-GC loaded with an aqueous extract of A. vera mucilage gel in a Cavia porcellus wound model. Thirty guinea pigs were divided in six groups, of five animals each. Three groups had two contralateral acute full-thickness wounds of 1 cm~2 (small wound); the remaining three had bigger (3cm2) full-thickness wounds (large wound). One small wound group and one large wound group were grafted on one side with CS-GC. Another small wound group and large wound group were grafted with CS-GC loaded with the aqueous extract of A. vera (CS-GCE). The two remaining groups were treated with gelatin-collagen microparticles loaded with the plant extract. In all cases contralateral wounds were left to close by secondary intention (control). Clinical follow-ups were made at 7,15,21, and 30 d to assess wound contraction, persistency of the scaffold, integration rate and wound contamination. At day 30th the animals were euthanized and skin biopsies were taken for histopathological and histomorphometric analysis. Animals were housed in a certified animal facility under controlled standard conditions and a veterinarian carried out all the experiments. Clinical, histologlcal and histomorphometric data indicate that CS-GCs loaded with the A. vera extract does not integrate into full-thickness skin wounds and have a degradation rate significantly lower than the one of CS-GC unloaded, probably because an interaction between the extract and the scaffold increase their cross-linking.
机译:支持组织生长的支架也可以设计用于控制常用为伤口愈合剂的植物提取物的释放。我们开发了Ⅰ型Ⅰ型支架,含有明胶 - 胶原的微粒(CS-GC),体外维持在跨越皮肤愈合的体内重塑阶段的时间内的芦荟术提取物的非细胞毒性浓度的释放。在全球范围内,这种植物的粘液凝胶和提取物在皮肤上以保湿剂,抗菌剂,抗炎症等使用。使用VERA制剂来促进皮肤伤口愈合已被哥伦比亚药物监管机构(INVIMA)批准。在这里,我们报告了脉瓣卷绕模型中含有A.Vera粘液凝胶水提取物的CS-GC的性能的预临床前评价。三十只豚鼠分为六组,每组五只动物。三组有两个对侧急性全厚度伤口,1cm〜2(伤口小);其余三个具有更大(3cm2)的全厚伤(大伤口)。用CS-GC一侧接枝一个小伤口和一个大伤口组。将另一个小伤口组和大型缠绕组接枝,CS-GC载有A.Vera(CS-GCE)的水提取物。将两个剩余的群体用植物提取物负载的明胶 - 胶原微粒处理。在所有情况下,留下对侧伤口的次要意图(对照)。临床随访时间为7,15,21和30 d,以评估伤口收缩,支架持续性,集成率和伤口污染。在第30天,动物被安乐死,并考虑皮肤活组织检查,用于组织病理学和组织素质分析。动物被安置在受控标准条件下的经过认证的动物设施中,兽医进行所有实验。临床,组织术和组织形态形状数据表明,随着A.Vera提取物的CS-GCS不整合到全厚的皮肤伤口中,并且具有显着低于卸载的CS-GC之一的降解速率,可能是因为提取物之间的相互作用并且脚手架增加了他们的交联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号